AFX-3772

N/A

Report date: 2022/11/13 11:45:14

Base Information

Drug NameAFX-3772

Drug Alias NameAFX-3772

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia, BacterialPneumonia, PneumococcalPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPuerto Rico

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAffinivax Inc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsPneumonia, BacterialPneumonia, PneumococcalPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A